Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 13.2B | 14.4B | 15.1B | 14.1B |
Cost of revenue | 12.2B | 12.3B | 12.6B | 11.3B |
Gross profit | 1.0B | 2.1B | 2.5B | 2.8B |
Operating expense | ||||
Research & development | 447.5M | 565.9M | 576.3M | 672.8M |
Selling general and admin | 147.0M | 162.7M | 163.5M | 187.6M |
Other operating expenses | 75.4M | 108.1M | 94.0M | 109.9M |
Operating income | 258.7M | 1.1B | 1.5B | 1.7B |
Non operating interest income | ||||
Income | 15.0M | 33.4M | 18.4M | 48.4M |
Expense | 8.7M | 8.4M | 10.1M | 23.4M |
Other income expense | — | — | — | — |
Pretax income | 332.7M | 1.2B | 1.5B | 1.7B |
Tax provision | 43.6M | 109.9M | 94.5M | 232.7M |
Net income | 289.0M | 1.1B | 1.4B | 1.5B |
Basic EPS | 0.0 | 0.1 | 0.2 | 0.2 |
Diluted EPS | 0.0 | 0.1 | 0.2 | 0.2 |
Basic average shares | 9.3B | 8.9B | 8.6B | 8.6B |
Diluted average shares | 9.3B | 8.9B | 8.6B | 8.6B |
EBITDA | 775.9M | 1.6B | 1.8B | 2.1B |
Net income from continuing op. | 289.0M | 1.1B | 1.4B | 1.5B |
Minority interests | -3.8M | -14.5M | -21.5M | -127.8M |
Preferred stock dividends | 0 | 0 | 0 | 0 |